Marta Español‐Rego

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial

Irati Zubizarreta, Georgina Flórez‐Grau, Gemma Vila et al. · Proceedings of the National Academy of Sciences · 2019 · 185 citations · Full text

Life Sciences, Immunology, Neurology +17

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies

Valentín Ortiz‐Maldonado, Susana Rives, María Castellà et al. · Molecular Therapy · 2020 · 156 citations · Full text

Medicine, Immunology, Oncology +17

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

Paula Rodríguez-Márquez, María Eréndira Calleja-Cervantes, Guillermo Serrano et al. · Science Advances · 2022 · 113 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

Aina Oliver‐Caldés, Verónica González‐Calle, Valentín Cabañas et al. · The Lancet Oncology · 2023 · 87 citations · Full text

Medicine, Hematology, Immunology +17

Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene

Estíbaliz Ruiz‐Ortiz, E. Iglesias, Alessandra Soriano et al. · Frontiers in Immunology · 2017 · 49 citations · Full text

Medicine, Immunology, Pediatrics +15